Delivery Order SPE2DB24D1205-SPE2DB24FCUFJ
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,177.97 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $26,194.08 and a period of performance through April 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has a ceiling value of $10,780.17 and a completion date of May 1, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 30 MG TABLET. The contract has a ceiling value of $22,446.03 and an ultimate completion date of October 7, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $8,853.78 firm fixed-price contract is for the delivery of RINVOQ ER 30 MG TABLET, a prescription medication. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide...
This is a $34,419.17 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product. It has an ultimate completion date of February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication. The contract has a ceiling value of $33,890.35 and an ultimate completion date of September 19, 2024. It is a firm fixed-price contract and does not have a set-aside designation. As a key supplier to various federal healthcare programs, including those...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has a ceiling value of $43,917.82 and an ultimate completion date of September 13, 2024. It is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $15,136.88. The contract has a firm fixed price pricing type and an ultimate completion date of May 7, 2025. The order is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $32,794.15 and a completion date of June 13, 2025. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a significant...